MONTEK LC TABLET 10'S

Montek LC Tablet 10's is a combination medicine used to treat symptoms of allergy such as runny nose, stuffy nose, sneezing, and watery eyes.

Montek LC Tablet 10's contains Montelukast and Levocetirizine as active ingredients.

Montek LC Tablet 10's is used to treat allergic rhinitis and its symptoms like sneezing, runny nose, watery eyes, and itching. It can also be used to treat asthma.

Common side effects of Montek LC Tablet 10's include drowsiness, fatigue, headache, and upset stomach.

Montek LC Tablet 10's can be taken with or without food. However, it is best to take it at the same time every day.

Yes, Montek LC Tablet 10's can cause drowsiness. Avoid driving or operating machinery if you feel dizzy or drowsy after taking this medicine.

Store Montek LC Tablet 10's at room temperature, away from direct sunlight and heat. Keep it out of reach of children and pets.

Montek LC Tablet 10's should be given to children only under the advice of a doctor.

Pregnant women should consult a doctor before taking Montek LC Tablet 10's.

Drinking alcohol with Montek LC Tablet 10's may increase the risk of drowsiness and other side effects.

In case of an overdose of Montek LC Tablet 10's, contact a doctor immediately or go to the nearest hospital.

Montek LC Tablet 10's can interact with certain medications. Therefore, inform your doctor about all your medications, including prescription drugs, over-the-counter drugs, and herbal products.

Montek LC Tablet 10's should be taken only for the duration prescribed by the doctor.

If you miss a dose of Montek LC Tablet 10's, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Yes, there are many other brands of Montelukast and Levocetirizine available. Consult with your doctor or pharmacist.

In many regions, Montek LC tablets commonly contain montelukast 10 mg and levocetirizine 5 mg. For adults and adolescents aged 15 years and above, doctors often prescribe one tablet once daily, usually in the evening. However, exact dosing must follow the strength and instructions on your specific product and your doctor’s prescription. Do not change the dose on your own.

You should not increase Montek LC to more than the prescribed daily dose without medical advice. Taking it more than once a day can raise the risk of side effects such as excessive drowsiness, headache, abdominal discomfort, and neuropsychiatric reactions. If your symptoms are not controlled with the prescribed once-daily regimen, consult your doctor to review your treatment plan rather than self-adjusting the dose.

Montek LC is often taken once daily in the evening, as this timing can help control night-time and early-morning allergy or asthma-related symptoms and may reduce daytime drowsiness from levocetirizine in some patients. Nevertheless, your doctor may recommend a different time based on your symptom pattern and lifestyle. Take it at the same time each day for consistent effect.

Montek LC can generally be taken with or without food. Taking it with food may help reduce the chance of stomach discomfort in sensitive individuals. The more important point is to take it consistently at the same time each day as directed by your doctor. Always follow the instructions on your prescription label and the patient information leaflet.

If you miss a dose of Montek LC, take it as soon as you remember, unless it is almost time for your next scheduled dose. If it is close to the next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two tablets at once or extra doses to make up for a missed one, as this may increase the risk of side effects.

The duration of daily Montek LC use depends on the underlying condition and your doctor’s assessment. Some adults may need it for a short seasonal allergy period, while others with persistent allergic rhinitis or asthma may be advised longer-term use with periodic review. Long-term therapy should always be supervised by a doctor, who will regularly reassess the need, dose, and safety based on your response and any side effects.

Dose considerations may be necessary in adults with kidney or liver impairment because levocetirizine is primarily excreted by the kidneys and montelukast is metabolised in the liver. In moderate to severe renal impairment, a lower dose or an alternative antihistamine may be required, and in significant hepatic impairment, montelukast-containing products may need caution or avoidance. Any adjustment must be made by a doctor after reviewing your kidney and liver function tests and overall clinical status.

You should not split, crush, or otherwise alter Montek LC tablets unless the product information specifically states that this is acceptable and your doctor has advised it. Splitting the tablet can lead to inaccurate dosing of each component (montelukast and levocetirizine), which may reduce effectiveness or increase side effects. If the prescribed dose does not match the available tablet strength, your doctor may choose a different formulation or regimen rather than tablet splitting.

The commonly used adult dose of one tablet once daily (for typical 10 mg montelukast plus 5 mg levocetirizine formulations) is generally applied across a wide adult age and weight range. However, individual factors such as body weight, age above 65 years, kidney or liver function, other medicines, and severity of disease can influence whether this standard dose is appropriate. Your doctor may adjust therapy or choose alternative treatments based on your individual risk–benefit profile.

In many adults using Montek LC for allergic rhinitis, the medicine can be stopped when the allergen exposure ends and symptoms have resolved, but this decision should be made with your doctor. Abrupt discontinuation is not usually associated with withdrawal effects; however, symptoms such as sneezing, nasal congestion, or wheeze may return if the underlying allergy or asthma is still active. Your doctor will advise whether to taper or stop based on your clinical course and risk of relapse.